Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
laboratory of Dr. Albert H. Kim at The Brain Tumor Center at WashU Medicine in St. Louis. The Kim lab is dedicated to understanding the molecular mechanisms that drive tumor cell behavior in glioblastoma, a
-
telephones, takes messages and forwards to appropriate persons. Maintains the daily appointment schedule for visitors and patient office visits. Maintains file system, including retrieval, copy and disposal
-
the diverse experiences and identities of every team member. What You’ll Do In this dynamic role, you’ll: Train and support users on nebulaONE and other AI platforms. Develop documentation, guides, and demos
-
technology services to students, faculty, staff, and researchers across all three campuses and UW Medicine. We’re currently seeking a Senior Workday Application System Engineer to join our dynamic Workday
-
), identifying specific genomic variants and their relationship to clinical manifestations, and understanding the molecular mechanisms behind these rare disorders. • Methods Development: Developing novel
-
-established protocols for routine molecular biology techniques to develop new cyanobacterial strains. Set up materials/labs. Collect data, maintain files on research, and assist with data entry. Assist with
-
Preferred Qualifications: Experience with basic molecular/cell biology techniques, as well as with stem cell and/or animal models of disease, is highly preferred. Preferred Qualifications Education: Ph.D
-
faculty for their studies on understanding the molecular mechanisms of tumor metastasis to bone and specifically how these processes can be targeted or inhibited to decrease tumor growth in bone and
-
, on the traditional territories of the Coast Salish people. Seattle is a rapidly growing, dynamic, and diverse metropolitan area with a leading technology sector and vibrant civic sector. Applicants may find further
-
the molecular pharmacology of calcium sensing and related G-protein coupled receptors (GPCRs). Our ENRG takes a “bedside to bench” approach leveraging access to human endocrine tumor samples, genomic